JP2024512931A5 - - Google Patents
Info
- Publication number
- JP2024512931A5 JP2024512931A5 JP2023556737A JP2023556737A JP2024512931A5 JP 2024512931 A5 JP2024512931 A5 JP 2024512931A5 JP 2023556737 A JP2023556737 A JP 2023556737A JP 2023556737 A JP2023556737 A JP 2023556737A JP 2024512931 A5 JP2024512931 A5 JP 2024512931A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- tautomer
- pharmaceutically acceptable
- acceptable salt
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021081514 | 2021-03-18 | ||
| CNPCT/CN2021/081514 | 2021-03-18 | ||
| PCT/CN2022/081544 WO2022194259A1 (en) | 2021-03-18 | 2022-03-17 | Receptor-interacting protein 1 inhibitors, preparations, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512931A JP2024512931A (ja) | 2024-03-21 |
| JP2024512931A5 true JP2024512931A5 (https=) | 2025-03-25 |
Family
ID=83321909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023556737A Pending JP2024512931A (ja) | 2021-03-18 | 2022-03-17 | 受容体相互作用タンパク質１阻害剤、その調製、及び使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240217963A1 (https=) |
| EP (1) | EP4308555A4 (https=) |
| JP (1) | JP2024512931A (https=) |
| CN (1) | CN117500795A (https=) |
| CA (1) | CA3209628A1 (https=) |
| IL (1) | IL305530A (https=) |
| WO (1) | WO2022194259A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024233544A1 (en) | 2023-05-10 | 2024-11-14 | Genzyme Corporation | Isoxazolidines as ripk1 inhibitors and use thereof |
| CN121487930A (zh) | 2023-05-10 | 2026-02-06 | 建新公司 | 作为ripk1抑制剂的异噁唑烷及其用途 |
| CN121079291A (zh) | 2023-05-10 | 2025-12-05 | 建新公司 | 作为ripk1抑制剂的异噁唑烷及其使用 |
| CN120607513A (zh) * | 2024-03-08 | 2025-09-09 | 山东全重生物医药科技有限公司 | Ripk1抑制剂、其制备方法及其在医药上的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2637620A1 (en) * | 2006-02-16 | 2007-08-30 | Boehringer Ingelheim International Gmbh | Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors |
| TW200815426A (en) * | 2006-06-28 | 2008-04-01 | Astrazeneca Ab | New pyridine analogues II 333 |
| WO2008005368A2 (en) * | 2006-06-30 | 2008-01-10 | Abbott Laboratories | Piperazines as p2x7 antagonists |
| ES2404580T3 (es) * | 2007-10-11 | 2013-05-28 | Glaxosmithkline Llc | Novedosos inhibidores de la ehs y uso de los mismos |
| JP2011510996A (ja) * | 2008-01-30 | 2011-04-07 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 新規ｓＥＨ阻害剤およびその使用 |
| CA2813162C (en) * | 2010-10-20 | 2015-06-16 | Pfizer Inc. | Pyridine-2- derivatives as smoothened receptor modulators |
| HUE039922T2 (hu) * | 2012-12-11 | 2019-02-28 | Takeda Pharmaceuticals Co | Heterociklusos vegyületek |
| WO2016101885A1 (en) * | 2014-12-24 | 2016-06-30 | National Institute Of Biological Sciences, Beijing | Necrosis inhibitors |
| EP3224245B1 (en) * | 2014-12-24 | 2018-09-12 | National Institute Of Biological Sciences, Beijing | Necrosis inhibitors |
| TWI730959B (zh) * | 2015-05-19 | 2021-06-21 | 英商葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之雜環醯胺 |
| TW201831464A (zh) * | 2016-11-18 | 2018-09-01 | 英商葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之雜環醯胺 |
| SG11202105250TA (en) * | 2018-11-20 | 2021-06-29 | Sironax Ltd | Cyclic Ureas |
| CN113272272B (zh) * | 2018-11-20 | 2023-04-07 | 圣瑞诺有限公司 | Rip1抑制剂 |
| KR20200087922A (ko) * | 2019-01-11 | 2020-07-22 | 보로노이바이오 주식회사 | (3-페닐이속사졸리딘-2-일)(피페리딘-4-일)메타논 유도체 및 이를 유효성분으로 포함하는 키나아제 관련 질환 치료용 약학적 조성물 |
-
2022
- 2022-03-17 CN CN202280022439.7A patent/CN117500795A/zh active Pending
- 2022-03-17 JP JP2023556737A patent/JP2024512931A/ja active Pending
- 2022-03-17 US US18/549,923 patent/US20240217963A1/en active Pending
- 2022-03-17 WO PCT/CN2022/081544 patent/WO2022194259A1/en not_active Ceased
- 2022-03-17 IL IL305530A patent/IL305530A/en unknown
- 2022-03-17 CA CA3209628A patent/CA3209628A1/en active Pending
- 2022-03-17 EP EP22770611.6A patent/EP4308555A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024512931A5 (https=) | ||
| JP2022550640A5 (https=) | ||
| IL283592B2 (en) | Inhibitors of apol1 and methods of using same | |
| JP2023553835A5 (https=) | ||
| JP2022529311A5 (https=) | ||
| JP2021523221A5 (https=) | ||
| JP2022519696A5 (https=) | ||
| JP2019512485A5 (https=) | ||
| JP2023539194A5 (https=) | ||
| JP2021523200A5 (https=) | ||
| CN104650069B (zh) | 4-甲基二氢嘧啶类化合物及其在药物中的应用 | |
| AR042087A1 (es) | Tieno (3,2b) piridin - 6- carbonitrilos y tieno (2,3-b) piridin- 5- carbonitrilos como inhibidores de proteinquinasas | |
| SK15892000A3 (sk) | Spôsob syntézy cox-2 inhibítorov a medziprodukty | |
| JP2018504437A5 (https=) | ||
| CA2880699A1 (en) | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b | |
| JP2022529518A5 (https=) | ||
| JP2022553841A5 (https=) | ||
| JP2024543934A5 (https=) | ||
| JP2020535124A5 (https=) | ||
| JP2025505644A5 (https=) | ||
| AU2002360238B2 (en) | Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof | |
| JP2021513543A5 (https=) | ||
| CA3209628A1 (en) | Receptor-interacting protein 1 inhibitors, preparations, and uses thereof | |
| JP2019529460A5 (https=) | ||
| JP2020516616A5 (https=) |